For research use only. We do not sell to patients.
Lusutrombopag
CAS No. : 1110766-97-6
Biological Activity：Lusutrombopag is an orally bioavailable thrombopoietin (TPO) receptor agonist, used for treatment of chronic liver disease.
Research Area：Inflammation/Immunology
Targets：Thrombopoietin Receptor
Related Screening Libraries:Drug Repurposing Compound Library Plus;FDA-Approved Drug Library Plus;FDA-Approved Drug Library Mini;Bioactive Compound Library Plus;Immunology/Inflammation Compound Library;FDA-Approved Drug Library;Drug Repurposing Compound Library;Orally Active Compound Library;FDA Approved & Pharmacopeial Drug Library;Targeted Diversity Library;EMA-Approved Drug Library;Human Metabolite Library;
Related Small Molecules:Avatrombopag-d8 hydrochloride;Rafutrombopag diolamine;Avatrombopag hydrochloride;Lusutrombopag-d13;Rafutrombopag;Hetrombopag;TPO agonist 1
Trending products：Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Fluorescent Dye | PROTAC | Isotope-Labeled Compounds | Oligonucleotides
About Us:
- MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use；
- Structurally and synthetically diverse biologically active compounds；
- roduct quality is the key to our success and we take pride in offering only the highest-grade products.；
- We provide HNMR, LC-MS, HPLC, stability testing and activity assays of our products to clients.；
- Product identity, quality, purity and activity are assured by our robust quality control programs and procedures.；
- Customized order volume ranging from milligrams to kilograms scale；
Structurally and synthetically diverse biologically active compounds；
We provide customer-oriented services. To explore more, please contact us at [email protected]. Our team will gladly assist you.
